ASCO Guidelines

164 Jaksot

1. Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2022.2 Part 1

   Julkaistiin: 19.12.2022
2. Immunotherapy and Biomarker Testing in Recurrent and Metastatic Head and Neck Cancers Guideline

   Julkaistiin: 15.12.2022
3. Use of Opioids for Adults with Pain from Cancer or Cancer Treatment Guideline

   Julkaistiin: 5.12.2022
4. Treatment of Metastatic Colorectal Cancer Guideline

   Julkaistiin: 17.10.2022
5. PARP Inhibitors in the Management of Ovarian Cancer Rapid Recommendation Update

   Julkaistiin: 3.10.2022
6. Secondary Prevention of Cervical Cancer Resource-Stratified Guideline Update

   Julkaistiin: 26.9.2022
7. Systemic Therapy Update on 177Lutetium-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: ASCO Rapid Recommendation Update

   Julkaistiin: 21.9.2022
8. Integrative Medicine for Pain Management in Oncology: SIO-ASCO Guideline

   Julkaistiin: 19.9.2022
9. Chemotherapy and Targeted Therapy for HER2-Negative Metastatic Breast Cancer that is Either Endocrine-Pretreated or Hormone Receptor–Negative: ASCO Guideline Rapid Recommendation Update

   Julkaistiin: 4.8.2022
10. Therapy for Stage IV Non-Small Cell Lung Cancer with Driver Alterations: ASCO Living Guideline (Part 2)

    Julkaistiin: 11.7.2022
11. Therapy for Stage IV Non-Small Cell Lung Cancer without Driver Alterations: ASCO Living Guideline (Part 1)

    Julkaistiin: 11.7.2022
12. Biomarkers for Systemic Therapy in Metastatic Breast Cancer Guideline Update

    Julkaistiin: 27.6.2022
13. Management of Metastatic Clear Cell Renal Cell Carcinoma Guideline

    Julkaistiin: 21.6.2022
14. Systemic Therapy for Melanoma Rapid Recommendation Update

    Julkaistiin: 3.6.2022
15. Systemic Therapy for Advanced HER2-Positive Breast Cancer Guideline Update

    Julkaistiin: 31.5.2022
16. Management of Advanced HER2-Positive Breast Cancer and Brain Metastases Guideline Update

    Julkaistiin: 31.5.2022
17. Exercise, Diet, and Weight Management During Cancer Treatment Guideline

    Julkaistiin: 16.5.2022
18. Radiation Therapy for Brain Metastases: ASCO Guideline Endorsement of ASTRO Guideline

    Julkaistiin: 13.5.2022
19. Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer Guideline Update

    Julkaistiin: 19.4.2022
20. Use of Immune Checkpoint Inhibitor Pembrolizumab in the Treatment of High-risk, Early-stage Triple Negative Breast Cancer Rapid Recommendation Update

    Julkaistiin: 13.4.2022